With a patent that will not expire until 2031 at the earliest (patent extensions are common), the cost is unlikely to decrease anytime soon, says Tanya Feke, MD, a health policy analyst
If they give you hesitancy with that, then thats a red flag
the scaffold and adapter proteins PAR-3 (two isoforms, PAR-3 and PAR-3 L, also known as PAR-3B, in vertebrates) and PAR-6 (three isoforms, PAR-6 A = PAR-6 C, PAR-6B, and PAR-6D = PAR-6 G in vertebrates)
Although AOD-9604 failed in the clinic, it remained popular in the research community around metabolic peptides
HOW TO USE: Before using, check this product visually for particles or discoloration
Always consult a qualified healthcare professional before considering peptide use